openPR Logo
Press release

Diamond Blackfan Anemia Market Unlocking New Revenue Opportunities and Strategic Expansion by 2036 - DelveInsight | Novartis AG, AstraZeneca, Pfizer Inc., Sanofi, Merck KGaA

06-05-2026 12:52 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Diamond Blackfan Anemia Market Unlocking New Revenue

The Key Diamond Blackfan Anemia Companies in the market include - Apriligen, Disc Medicines, Novartis AG, AstraZeneca, Pfizer Inc., Sanofi, Merck KGaA, and others.

DelveInsight's "Diamond Blackfan Anemia Market Insights, Epidemiology, and Market Forecast-2036 report offers an in-depth understanding of the Diamond Blackfan Anemia, historical and forecasted epidemiology as well as the Diamond Blackfan Anemia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

The latest healthcare forecast report provides an in-depth analysis of Diamond Blackfan Anemia, offering comprehensive insights into the Diamond Blackfan Anemia revenue trends, prevalence, and treatment landscape. The report delves into key Diamond Blackfan Anemia statistics, highlighting the current and projected market size, while examining the efficacy and development of emerging Diamond Blackfan Anemia therapies. Additionally, we cover the landscape of Diamond Blackfan Anemia clinical trials, providing an overview of ongoing and upcoming studies that are poised to shape the future of Diamond Blackfan Anemia treatment. This report is an essential resource for understanding the market dynamics and the evolving therapeutic options within the Diamond Blackfan Anemia space.

Get a Free sample for the Diamond Blackfan Anemia Market Forecast, Size & Share Analysis Report:

https://www.delveinsight.com/report-store/diamond-blackfan-anemia-dba-aase-syndrome-market [https://www.delveinsight.com/report-store/diamond-blackfan-anemia-dba-aase-syndrome-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Some of the key facts of the Diamond Blackfan Anemia Market Report:

*
The Diamond Blackfan Anemia market size was valued at approximately USD 1.6 million in 2025 and is projected to grow at a CAGR of 3% during the forecast period from 2026 to 2036.

*
In August 2025, Apriligen announced the filing of an Investigational New Drug (IND) application with the US FDA for APR-2020.

*
In September 2025, the US FDA granted a "safe to proceed" clearance to Apriligen for APR-2020, enabling the initiation of clinical studies.

*
According to the estimates, the largest market size of DBA is to be from the United States in 2025.

*
Key Diamond Blackfan Anemia Companies: Apriligen, Disc Medicines, Novartis AG, AstraZeneca, Pfizer Inc., Sanofi, Merck KGaA, and others

*
Key Diamond Blackfan Anemia Therapies: Bitopertin, APR-2020, Deferasirox, and others

*
Among the 7MM, the United States accounted for the highest number of Diamond Blackfan Anemia Diagnosed Prevalent Cases in 2025, with nearly 6,000 cases. These cases are anticipated to increase by 2036.

*
In the United States, the RPS19 mutation accounted for ~25% cases in 2025 among diamond blackfan anemia cases by mutation.

*
Among the EU4 and the UK, approximately 25% of diamond blackfan anemia cases in 2025 were reported to be of the craniofacial type, followed by cases with musculoskeletal, urogenital, and other congenital anomalies.

*
In Japan, among the congenital anomalies associated with Diamond-Blackfan anemia, craniofacial anomalies were the most prevalent, with almost 50 cases reported in 2025, followed by musculoskeletal anomalies.

Diamond Blackfan Anemia Overview

Diamond Blackfan Anemia (DBA) is a rare inherited bone marrow disorder where the body fails to produce enough red blood cells, leading to severe anemia. It typically presents in infancy or early childhood with symptoms like fatigue, pale skin, and poor growth. Many patients may also have physical abnormalities, such as facial features, thumb or limb defects, and heart problems. DBA is often caused by mutations in genes affecting ribosome production. Treatment usually includes corticosteroids, regular blood transfusions, and in some cases, bone marrow transplantation. Ongoing research is exploring gene therapies and other targeted treatments for DBA.

To Know in detail about the Diamond Blackfan Anemia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Diamond Blackfan Anemia Market Forecast [https://www.delveinsight.com/sample-request/diamond-blackfan-anemia-dba-aase-syndrome-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Diamond Blackfan Anemia Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2022 to 2036. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Diamond Blackfan Anemia Epidemiology Segmentation:

The Diamond Blackfan Anemia market report proffers epidemiological analysis for the study period 2022-2036 in the 7MM segmented into:

*
Total Diagnosed Prevalent Cases of Diamond-Blackfan Anemia

*
Total Diagnosed Prevalent Cases of Diamond-Blackfan Anemia (DBA) by Mutated Gene

*
Total Diagnosed Prevalent Cases of Diamond-Blackfan Anemia (DBA) by Congenital Anomaly

*
Total Treated Cases of Diamond Blackfan Anemia

Download the report to understand which factors are driving Diamond Blackfan Anemia epidemiology trends @ Diamond Blackfan Anemia Epidemiology Forecast [https://www.delveinsight.com/sample-request/diamond-blackfan-anemia-dba-aase-syndrome-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Diamond Blackfan Anemia Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Diamond Blackfan Anemia market or expected to get launched during the study period. The analysis covers Diamond Blackfan Anemia market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Diamond Blackfan Anemia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Diamond Blackfan Anemia Therapies and Key Companies

*
Bitopertin: Disc Medicines

*
APR-2020: Apriligen

*
Deferasirox: Novartis

Discover more about therapies set to grab major Diamond Blackfan Anemia market share @ Diamond Blackfan Anemia Treatment Landscape [https://www.delveinsight.com/sample-request/diamond-blackfan-anemia-dba-aase-syndrome-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Diamond Blackfan Anemia Market Drivers

*
Rising awareness of rare genetic disorders and improved diagnostic capabilities

*
Advancements in gene therapy and novel targeted treatments under development

*
Increasing research funding and orphan drug designations encouraging innovation

*
Growing patient advocacy and support networks driving demand for better therapies

*
Availability of stem cell and bone marrow transplant techniques improving patient outcomes

Diamond Blackfan Anemia Market Barriers

*
Limited patient population due to the ultra-rare nature of the disease, reducing commercial incentive

*
High treatment costs, especially for gene therapies and transplants, creating access challenges

*
Complex regulatory approval pathways for rare disease therapies

*
Lack of long-term safety and efficacy data for emerging treatments

Scope of the Diamond Blackfan Anemia Market Report

*
Study Period: 2022-2036

*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

*
Key Diamond Blackfan Anemia Companies: Apriligen, Disc Medicines, Novartis AG, AstraZeneca, Pfizer Inc., Sanofi, Merck KGaA, and others

*
Key Diamond Blackfan Anemia Therapies: Bitopertin, APR-2020, Deferasirox, and others

*
Diamond Blackfan Anemia Therapeutic Assessment: Diamond Blackfan Anemia current marketed and Diamond Blackfan Anemia emerging therapies

*
Diamond Blackfan Anemia Market Dynamics: Diamond Blackfan Anemia market drivers and Diamond Blackfan Anemia market barriers

*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies

*
Diamond Blackfan Anemia Unmet Needs, KOL's views, Analyst's views, Diamond Blackfan Anemia Market Access and Reimbursement

To know more about Diamond Blackfan Anemia companies working in the treatment market, visit @ Diamond Blackfan Anemia Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/diamond-blackfan-anemia-dba-aase-syndrome-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Table of Contents

1. Diamond Blackfan Anemia Market Report Introduction

2. Executive Summary for Diamond Blackfan Anemia

3. SWOT analysis of Diamond Blackfan Anemia

4. Diamond Blackfan Anemia Patient Share (%) Overview at a Glance

5. Diamond Blackfan Anemia Market Overview at a Glance

6. Diamond Blackfan Anemia Disease Background and Overview

7. Diamond Blackfan Anemia Epidemiology and Patient Population

8. Country-Specific Patient Population of Diamond Blackfan Anemia

9. Diamond Blackfan Anemia Current Treatment and Medical Practices

10. Diamond Blackfan Anemia Unmet Needs

11. Diamond Blackfan Anemia Emerging Therapies

12. Diamond Blackfan Anemia Market Outlook

13. Country-Wise Diamond Blackfan Anemia Market Analysis (2022-2036)

14. Diamond Blackfan Anemia Market Access and Reimbursement of Therapies

15. Diamond Blackfan Anemia Market Drivers

16. Diamond Blackfan Anemia Market Barriers

17. Diamond Blackfan Anemia Appendix

18. Diamond Blackfan Anemia Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=diamond-blackfan-anemia-market-unlocking-new-revenue-opportunities-and-strategic-expansion-by-2036-delveinsight-novartis-ag-astrazeneca-pfizer-inc-sanofi-merck-kgaa]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: https://www.delveinsight.com/
Country: United States
Website: https://www.delveinsight.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Diamond Blackfan Anemia Market Unlocking New Revenue Opportunities and Strategic Expansion by 2036 - DelveInsight | Novartis AG, AstraZeneca, Pfizer Inc., Sanofi, Merck KGaA here

News-ID: 4539047 • Views:

More Releases from ABNewswire

Diabetic Neuropathic Pain Market is Projected to Grow Significantly by 2034 Owing to the Launch of Emerging Therapies | DelveInsight
Diabetic Neuropathic Pain Market is Projected to Grow Significantly by 2034 Owin …
The market dynamics for Diabetic Neuropathic Pain are witnessing steady growth driven by the rising prevalence of diabetes, increasing burden of neuropathic complications, growing demand for effective symptomatic therapies, and advancements in pain management approaches. Additionally, the launch of emerging therapies such as Suzetrigine (Vertex Pharmaceuticals), Pilavapadin/LX9211 (Lexicon Pharmaceuticals), and others will further fuel the market. DelveInsight, a leading market research firm, announces the release of its latest report, "DelveInsight's Diabetic
EGFR Inhibitors-induced Skin Disorders Market is Projected to Grow by 2036 Owing to the Rising Use of Targeted Cancer Therapies and Emerging Novel Treatment Approaches | DelveInsight
EGFR Inhibitors-induced Skin Disorders Market is Projected to Grow by 2036 Owing …
The market dynamics for EGFR Inhibitors-induced Skin Disorders are witnessing significant growth driven by the increasing use of EGFR inhibitors across multiple cancer indications, rising incidence of dermatologic toxicities associated with anti-EGFR therapies, and growing demand for effective supportive care management strategies. Additionally, the launch of emerging therapies such as LUT-014 (Lutris Pharma), HT-001 (Hoth Therapeutics), ATR-04 (Azitra), and others will further fuel the market. DelveInsight, a leading market research firm,
Actinic Keratosis Market is Projected to Grow by 2036 Owing to the Rising Disease Burden and Emerging Novel Therapies | DelveInsight
Actinic Keratosis Market is Projected to Grow by 2036 Owing to the Rising Diseas …
The market dynamics for Actinic Keratosis are witnessing substantial growth driven by the increasing prevalence of chronic sun exposure-related skin disorders, growing awareness regarding early diagnosis and treatment of precancerous lesions, and rising adoption of field-directed therapies and photodynamic treatment approaches. Additionally, the launch of emerging therapies such as Tuvatexib (VDA-1102) by Vidac Pharma and RLS-1496 by Rubedo Life Sciences will further fuel the market. DelveInsight, a leading market research firm,
Gene and Cell Therapies Targeting CNS Disorders Market Expected to Experience Accelerated Growth and Market Evolution by 2036 - DelveInsight | Brainstorm Cell Therapeutics, MeiraGTx, Voyager Thera
Gene and Cell Therapies Targeting CNS Disorders Market Expected to Experience Ac …
The Key Gene and Cell Therapies Targeting CNS Disorders Companies in the market include - In8bio Inc., Brainstorm Cell Therapeutics, Neurocrine Biosciences, Voyager Therapeutics, Atara Biotherapeutics, Neuroplast, UniQure Biopharma, Asklepios Biopharmaceutical, Inc., Lexeo Therapeutics, Partner Therapeutics, Inc., Hoffmann-La Roche, Novartis, Freeline Therapeutics, Passage Bio, Inc., Black Diamond Therapeutics, Inc., and others. DelveInsight's "Gene and Cell Therapies Targeting CNS Disorders Market Insights, Epidemiology, and Market Forecast-2036 report offers an in-depth understanding of

All 5 Releases


More Releases for Diamond

Industrial Diamond Market Hits New High | Major Giants Sandvik, Zhongnan Diamond …
HTF MI just released the Global Industrial Diamond Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach. 𝐌𝐚𝐣𝐨𝐫 Giants in Industrial Diamond Market are: De Beers Group, Element Six,
Diamond Wire Rope Market 2023: Companies Revenue Analysis- Diamond WireTec, Asah …
The Diamond Wire Rope market research report is proficient and top to bottom research by specialists on the current state of the industry. This statistical surveying report gives the most up to date industry information and industry future patterns, enabling you to distinguish the items and end clients driving income development and benefit. It centres around the real drivers and restrictions for the key players and present challenge status with
Synthetic Diamond Market Seeking Excellent Growth | New Diamond Technology, Appl …
Advance Market Analytics published a new research publication on "Synthetic Diamond Market Insights, to 2027" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Synthetic Diamond market was mainly driven by the increasing R&D spending across the world. Get Free Exclusive PDF Sample Copy of
Jewelry Diamond Market is Booming Worldwide | Zhongnan Diamond, Jinqu Chaoying D …
Latest launched research document on Global Jewelry Diamond Market study of 115 Pages provides detailed analysis with presentable graphs, charts and tables. The Research Study presents a complete assessment of the Market and highlights future trend, growth factors & drivers, leaders opinions, facts, and primary validated market data. The research study provides estimates for Global Jewelry Diamond Forecast till 2026*. How to reach that market place and its associated audience with
Synthetic Diamond Market | Key Players - Include Element Six (E6), Applied Diamo …
As per the current market trends and the promising nature of the Global Synthetic Diamond Market, it can be estimated that the future holds positive outcomes. In order to provide a deep insight about the concerned market, Market Research Reports Search Engine would be publishing a resourceful analysis that will enclose knowledge about the regional market size, revenue and opportunity status. Readers will be offered the privilege to decode various
Global Industrial Diamond Sales Market 2017 - Advanced Diamond Solutions, Applie …
The Industrial Diamond Sales market research report distils the most essential aspects of the market and presents them in the form of a comprehensive and cohesive document. The findings of this report have been obtained via a balanced mix of both primary and secondary research. Interviews of C-level executives in the Industrial Diamond Sales market form a chunk of the qualitative analysis contained in this report. Download Sample Report @